EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Epigenetic Mechanisms in Autoimmune Thyroid Diseases: Bridging Research and Clinical Applications

Shouxia Xiao, Yuelin Hu, Xin Wang, Hongsong Yu iD

International Journal of Molecular Sciences · 07.12.2025 · 26 (24) · 11823

DOI: 10.3390/ijms262411823 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 07.12.2025. Verfasst von Shouxia Xiao und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, Special Key Laboratory of Gene Detection and Therapy of Guizhou Province, Zunyi Medical University, Zunyi 563000, China. Hauptthemen laut MEDLINE: Epigenesis, Genetic, Hashimoto Disease, Autoimmune Diseases, Thyroid Diseases. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 137 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Autoimmune thyroid disease (AITD) exemplifies an organ-specific autoimmune disorder, including Hashimoto’s thyroiditis (HT) and Graves’ disease (GD). HT is characterized by hypothyroidism, whereas GD primarily presents as hyperthyroidism. Immunological evidence indicates that AITD pathogenesis requires both a permissive genetic background and environmental triggers to initiate and sustain disease progression. However, the exact molecular and cellular pathways through which these elements synergize to trigger and sustain autoimmune responses remain unclear. Emerging evidence suggests that epigenetic regulation serves as the key interface decoding genetic predisposition through environmental stimuli in AITD etiology. Studies show that environmental epigenetic reprogramming initiates AITD development in genetically susceptible individuals. Epigenetic regulators, including DNA methylation, histone modifications, and non-coding RNA activity, finely tune transcriptional outputs to influence disease trajectories. Beyond elucidating AITD pathogenesis, these epigenetic alterations offer clinical value as diagnostic biomarkers and modifiable therapeutic targets, facilitating precision medicine approaches from early detection to customized interventions. These epigenetic modifications not only elucidate AITD pathophysiology but also provide measurable markers for early diagnosis and molecular targets for personalized treatment strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epigenesis, GeneticHashimoto DiseaseAutoimmune DiseasesThyroid DiseasesHumansDNA MethylationGraves DiseaseAnimalsGenetic Predisposition to Disease

Stichwörter der Autor:innen

DNA methylationGraves’ diseaseHashimoto’s thyroiditisautoimmune thyroid diseasehistone modificationnon-coding RNA

Autor:innen und Institutionen

  • Department of Immunology, Special Key Laboratory of Gene Detection and Therapy of Guizhou Province, Zunyi Medical University, Zunyi 563000, China.
  • School of Basic Medical Sciences, Key Laboratory of Cancer Prevention and Treatment of Guizhou Province, Zunyi Medical University, Zunyi 563000, China.

ORCID-Profile: Hongsong Yu

Zitieren

APA

Xiao, S., Hu, Y., Wang, X., & Yu, H. (2025). Epigenetic Mechanisms in Autoimmune Thyroid Diseases: Bridging Research and Clinical Applications. International Journal of Molecular Sciences, 26(24), 11823. https://doi.org/10.3390/ijms262411823

Vancouver

Xiao S, Hu Y, Wang X, Yu H. Epigenetic Mechanisms in Autoimmune Thyroid Diseases: Bridging Research and Clinical Applications. International Journal of Molecular Sciences. 2025;26(24):11823. doi:10.3390/ijms262411823

BibTeX
@article{Xiao2025,
  author = {Xiao, Shouxia and Hu, Yuelin and Wang, Xin and Yu, Hongsong},
  title = {Epigenetic Mechanisms in Autoimmune Thyroid Diseases: Bridging Research and Clinical Applications},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {24},
  pages = {11823},
  doi = {10.3390/ijms262411823}
}
Kostenlos starten →